| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.46 | 7e-12 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.006 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |